| P50 | author | Steven Rosenberg | Q2347448 |
| P2093 | author name string | Paul A Antony | |
| | Mojgan Ahmadzadeh | |
| P2860 | cites work | Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation | Q24291515 |
| | FOXP3 controls regulatory T cell function through cooperation with NFAT | Q24298179 |
| | Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells | Q24298812 |
| | Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells | Q24645614 |
| | Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 |
| | Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 |
| | Regulatory T cell lineage specification by the forkhead transcription factor foxp3 | Q28510328 |
| | A function for interleukin 2 in Foxp3-expressing regulatory T cells | Q28590646 |
| | Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival | Q29547865 |
| | An essential role for Scurfin in CD4+CD25+ T regulatory cells | Q29618395 |
| | X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy | Q29619109 |
| | Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses | Q29619908 |
| | Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development | Q34597933 |
| | Phenotypic and functional maturation of tumor antigen-reactive CD8+ T lymphocytes in patients undergoing multiple course peptide vaccination | Q34648472 |
| | Interleukin-2-dependent mechanisms of tolerance and immunity in vivo | Q34655265 |
| | IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients | Q34657691 |
| | Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy | Q34936175 |
| | Human CD4+CD25+ regulatory T cells | Q35703495 |
| | High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT | Q35849935 |
| | Tolerance, not immunity, crucially depends on IL-2. | Q35877199 |
| | A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. | Q36078042 |
| | Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma | Q36119828 |
| | Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization | Q36402763 |
| | Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia | Q36403785 |
| | FOXP3: of mice and men. | Q36427333 |
| | Immunosuppression in melanoma immunotherapy: potential opportunities for intervention | Q36445961 |
| | TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells | Q36924688 |
| | Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells | Q41908906 |
| | IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo | Q42139164 |
| | TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs | Q42181372 |
| | Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma | Q45287769 |
| | Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function | Q47579310 |
| | Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. | Q54645452 |
| | Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells | Q81357564 |
| P433 | issue | 3 | |
| P304 | page(s) | 294-302 | |
| P577 | publication date | 2007-04-01 | |
| P1433 | published in | Journal of Immunotherapy | Q15763946 |
| P1476 | title | IL-2 and IL-15 each mediate de novo induction of FOXP3 expression in human tumor antigen-specific CD8 T cells | |
| P478 | volume | 30 | |